142 related articles for article (PubMed ID: 10482182)
1. Markers of androgen-independent progression of prostatic carcinoma.
Daliani D; Papandreou CN
Semin Oncol; 1999 Aug; 26(4):399-406. PubMed ID: 10482182
[TBL] [Abstract][Full Text] [Related]
2. Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models.
Denmeade SR; Sokoll LJ; Dalrymple S; Rosen DM; Gady AM; Bruzek D; Ricklis RM; Isaacs JT
Prostate; 2003 Mar; 54(4):249-57. PubMed ID: 12539223
[TBL] [Abstract][Full Text] [Related]
3. The clinical and biological study of androgen independent prostate cancer (AI PCa).
Logothetis CJ; Hoosein NM; Hsieh JT
Semin Oncol; 1994 Oct; 21(5):620-9. PubMed ID: 7524155
[No Abstract] [Full Text] [Related]
4. In vitro modulation of tumor progression-associated properties of hormone refractory prostate carcinoma cell lines by cytokines.
Sokoloff MH; Tso CL; Kaboo R; Taneja S; Pang S; deKernion JB; Belldegrun AS
Cancer; 1996 May; 77(9):1862-72. PubMed ID: 8646686
[TBL] [Abstract][Full Text] [Related]
5. Potential establishment of lung metastatic xenograft model of androgen receptor-positive and androgen-independent prostate cancer (C4-2B).
Yamamichi F; Matsuoka T; Shigemura K; Kawabata M; Shirakawa T; Fujisawa M
Urology; 2012 Oct; 80(4):951.e1-7. PubMed ID: 22920407
[TBL] [Abstract][Full Text] [Related]
6. The role of the androgen receptor in the development and progression of prostate cancer.
Jenster G
Semin Oncol; 1999 Aug; 26(4):407-21. PubMed ID: 10482183
[TBL] [Abstract][Full Text] [Related]
7. [Prostatic markers, today and tomorrow].
Terrone C; Faraone N; Aimo G; Priolo G
Recenti Prog Med; 2000 Nov; 91(11):576-80. PubMed ID: 11125951
[No Abstract] [Full Text] [Related]
8. Hormones and prostate cancer: what's next?
Hsing AW
Epidemiol Rev; 2001; 23(1):42-58. PubMed ID: 11588854
[TBL] [Abstract][Full Text] [Related]
9. MicroRNAs in androgen-dependent PCa.
Zhu KC; Lu JJ; Xu XL; Sun JM
Front Biosci (Landmark Ed); 2013 Jan; 18(2):748-55. PubMed ID: 23276959
[TBL] [Abstract][Full Text] [Related]
10. Ligand-independent activation of the androgen receptor in prostate cancer by growth factors and cytokines.
Jenster G
J Pathol; 2000 Jul; 191(3):227-8. PubMed ID: 10878541
[TBL] [Abstract][Full Text] [Related]
11. The importance of steroid hormones in prostate cancer.
Wilding G
Cancer Surv; 1992; 14():113-30. PubMed ID: 1423327
[TBL] [Abstract][Full Text] [Related]
12. Prostate cancer: molecular biology of early progression to androgen independence.
Sadar MD; Hussain M; Bruchovsky N
Endocr Relat Cancer; 1999 Dec; 6(4):487-502. PubMed ID: 10730903
[TBL] [Abstract][Full Text] [Related]
13. Prognostic markers in localized prostate cancer: from microscopes to molecules.
Harding MA; Theodorescu D
Cancer Metastasis Rev; 1998-1999; 17(4):429-37. PubMed ID: 10453287
[TBL] [Abstract][Full Text] [Related]
14. Androgen receptor and prostate cancer: molecular aspects and gene expression profiling.
Sommer A; Haendler B
Curr Opin Drug Discov Devel; 2003 Sep; 6(5):702-11. PubMed ID: 14579520
[TBL] [Abstract][Full Text] [Related]
15. Sensitivity of HOXB13 as a Diagnostic Immunohistochemical Marker of Prostatic Origin in Prostate Cancer Metastases: Comparison to PSA, Prostein, Androgen Receptor, ERG, NKX3.1, PSAP, and PSMA.
Kristiansen I; Stephan C; Jung K; Dietel M; Rieger A; Tolkach Y; Kristiansen G
Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28555048
[TBL] [Abstract][Full Text] [Related]
16. [Expression and regulation of androgen receptor in the androgen-independent conversion of prostate cancer cells].
Wang HF; Liu WJ; Jin J; Zhou LQ; Liang LL; Wang Y; Guo YL
Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Aug; 43(4):490-5. PubMed ID: 21844951
[TBL] [Abstract][Full Text] [Related]
17. [Androgen-dependent tumor].
Shimazaki J; Furuya Y; Sato N; Ichikawa T
Nihon Naibunpi Gakkai Zasshi; 1993 Jan; 69(1):16-24. PubMed ID: 8449242
[TBL] [Abstract][Full Text] [Related]
18. Evolution of the androgen receptor pathway during progression of prostate cancer.
Hendriksen PJ; Dits NF; Kokame K; Veldhoven A; van Weerden WM; Bangma CH; Trapman J; Jenster G
Cancer Res; 2006 May; 66(10):5012-20. PubMed ID: 16707422
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of naturally occurring and synthetic organoselenium compounds on biomarkers in androgen responsive and androgen independent human prostate carcinoma cells.
Pinto JT; Sinha R; Papp K; Facompre ND; Desai D; El-Bayoumy K
Int J Cancer; 2007 Apr; 120(7):1410-7. PubMed ID: 17205524
[TBL] [Abstract][Full Text] [Related]
20. Signal transduction in prostate cancer progression.
Gioeli D
Clin Sci (Lond); 2005 Apr; 108(4):293-308. PubMed ID: 15603554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
